Quantcast

Latest IsoRay Inc. Stories

2008-11-13 09:00:37

IsoRay Inc. (AMEX:ISR) a medical isotope company focusing on the treatment of prostate and other malignant disease through use of its proprietary radioisotope technology, today announced its financial results for the first quarter ended September 30, 2008. IsoRay Chairman and Interim CEO Dwight Babcock said sales revenue for the quarter decreased by 18 percent to approximately $1,519,583 as compared to approximately $1,855,719 in the year-earlier period. However, medical centers ordering...

2008-11-06 09:00:45

IsoRay Inc. (AMEX:ISR), a medical isotope company focused on the treatment of prostate cancer and other malignant disease through use of its proprietary radioisotope technology, announced today it will release first quarter results on Thursday, November 13, 2008, before market opening. That same day, at 4:30 p.m. ET, management will host a conference call, which will be broadcast live over the Internet. Participants should dial into the call 10-15 minutes before the scheduled time using...

2008-08-20 09:01:30

IsoRay Inc. (AMEX:ISR), a medical isotope company focused on the treatment of prostate cancer and other malignant disease through use of its proprietary radioisotope technology, announces today its financial results for the quarter and year ended June 30, 2008. "This year has seen many changes at IsoRay," said IsoRay Chairman and CEO Dwight Babcock. "We have made significant steps in focusing on the core business, gaining efficiencies, lowering the cost structure, and reducing cash...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related